Evidence map›Paper›PMID 38139307›Full record

ArticleInternational journal of molecular sciences2023

Isolation of Pro-Osteogenic Compounds from

Ryuichiro Suzuki, Yoshiaki Shirataki, Akito Tomomura, Kenjiro Bandow, Hiroshi Sakagami, Mineko Tomomura

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Novel Osteoblastogenic Activity ofInternational journal of molecular sciences · 2026
    Article
  2. Osteoprotective Activity ofAntioxidants (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ryuichiro SuzukiDepartment of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado 350-0295, Saitama, Japan.
Yoshiaki ShiratakiDepartment of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado 350-0295, Saitama, Japan.
Akito TomomuraDivision of Biochemistry, Department of Oral Biology & Tissue Engineering, Meikai University School of Dentistry, Sakado 350-0283, Saitama, Japan.
Kenjiro BandowDivision of Biochemistry, Department of Oral Biology & Tissue Engineering, Meikai University School of Dentistry, Sakado 350-0283, Saitama, Japan.ORCID 0000-0002-1362-3034
Hiroshi SakagamiMeikai University Research Institute of Odontology (M-RIO), Sakado 350-0283, Saitama, Japan.ORCID 0000-0001-8001-2121
Mineko TomomuraDepartment of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado 350-0295, Saitama, Japan.
Meikai University · JPJosai University · JP

Funding

Japan Society for the Promotion of Science 19K10060
6 · The paper itself

Abstract

Plants contain a large number of small-molecule compounds that are useful for targeting human health and in drug discovery. Healthy bone metabolism depends on the balance between bone-forming osteoblast activity and bone-resorbing osteoclast activity. In an ongoing study searching for 22 plant extracts effective against osteoporosis, we found that the crude extract of

Indexed as

Bone ResorptionOsteoporosisCell DifferentiationHumansOsteoblastsOsteoclastsOsteogenesisastragalinEuptelea polyandra Sieb. et Zuccisoquercitrinosteoblastosteoclastosteoporosis

Identifiers

PMID38139307
PMCPMC10743613
OpenAlexW4389793004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.